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1. Introduction 
1.1 The Huntington’s Disease 
Huntington’s Disease (HD) is a devastating autosomal dominanta neurodegenerative 
human disease for which there is currently no cure. HD is characterized by progressive 
motor, cognitive, and psychiatric symptoms (Huntington 1872). The gene responsible for 
HD (HTT) encodes the ubiquitously expressed Huntingtin protein (Htt) (MacDonald et al. 
1993) (Fig. 1). Human Htt is essential for brain development (Reiner et al. 2003), although its 
exact biological function is unknown. This protein is located mostly in the cytoplasm, but a 
small amount of Htt is also present in the nucleus (Kegel et al. 2002). Moreover, the protein 
can dynamically travel back and forth between the two cellular compartments (Kegel et al. 
2002). Htt may be associated also with the plasma membrane, the endocytic and autophagic 
vesicles, the endosomal compartments, the endoplasmic reticulum, the Golgi apparatus, 
mitochondria and microtubules (Kegel et al. 2002; Caviston et al. 2007; Kegel et al. 2005; 
Rockabrand et al. 2007; Strehlow et al. 2007; Atwal et al. 2007). Htt is a large, multidomain 
protein (3144 aa and molecular weight 348 kDa) for which structural information at atomic 
resolution is not available (Zuccato et al. 2010). Htt has been proposed to be an elongated 
super-helical solenoid with a diameter of ∼ 200 Å (Li et al. 2006) (Fig. 1). The best-
characterized part of the protein is the Exon 1 (Ex1), which consists of the following regions: 
N17 (the 17-amino acid-long N-term), the variable polyQ stretch (less than 36 Qs in healthy 
individuals (Mangiarini et al. 1996)), and a polyProline (polyP)-rich region (Fig. 1). Ex1, with 
an extended polyQ tract (m-Ex1), is sufficient to cause HD-like pathology in animal models 
(Mangiarini et al. 1996). Moreover, expression of m-Ex1 is sufficient to cause the typical 
formation of Htt aggregates found in brains of HD patients (Mangiarini et al. 1996; Bates et 
al. 1998; Davies et al. 1997). Hence, investigations of structural, dynamical and kinetic 
properties of m-Ex1 may help to understand key aspects of the disease. The amino acids of 
N17 are highly conserved (100% similarity) in all vertebrate species (Tartari et al. 2008), and 
                                                 
aAutosomal dominant conditions are achieved in cases in which a mutated gene from one parent is 
sufficient to cause a disease, in spite of the presence of a normal gene inherited from the other parent 
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N17 was originally believed to be unstructured (Perutz 1999). However, mutational analysis 
in vivo and Circular Dicroism (CD) (Atwal et al. 2007; Thakur et al. 2009) spectroscopy and 
NMR (Thakur et al. 2009) on peptides in vitro pointed out that this polypeptide may be an 
amphipathic α-helix with membrane-associating properties with respect to the endoplasmic 
reticulum (Atwal et al. 2007). The polyQ stretch begins at the 18th amino acid in human Htt 
(MacDonald et al. 1993).b  
In 1994, Max Perutz (Perutz 1994) suggested, for the first time, that the physiological 
function of polyQ was to bind transcription factors containing also a polyQ region. 
Consistently, it was later shown that the polyQ tract is a key regulator of Htt binding to its 
partners (Harjes & Wanker, 2003). This hypothesis is supported by the presence of HEAT 
repeats (Fig. 1) along the Htt sequence, which favor protein-protein interactions (Andrade & 
Bork 1995). Moreover, the polyQ region may have flexible and multifunctional structures, 
which can assume specific conformations and different activities, depending on its binding 
partners, on its sub-cellular location, and on time of maturation in a given cell type and 
tissue (Kim et al. 2009; Zuccato et al. 2010). 
The polyQ region is followed by a polyP tract (Tartari et al. 2008). This latter may affect the 
stability of the polyQ segment by keeping it soluble (Bhattacharyya et al. 2006; Steffan et al. 
2004). Hence, it may protect polyQ against its conformational collapse. In addition, the 
polyP may also work also as a protein-interaction domain. Consistent with these 
hypotheses, structural data provided hints that the polyQ’s aggregation and toxicity are 
influenced by the COOH-terminal polyP region (Kim et al. 2009; Bhattacharyya et al. 2006).  
1.2 Mutated huntingtin in HD and the role of polyQ 
The causative mutation of Htt is an abnormal expansion of CAG trinucleotide repeats within 
the coding sequence of the gene. The expansion leads to an elongated stretch of Q residues 
beyond the first 17 amino acids (MacDonald et al. 1993). In healthy individuals the number 
of Qs repeats is 35 or fewer, with 17–20 repeats found most commonly (Myers 2004; 
Housman 1995; Leavitt et al. 1999; Leavitt et al. 2001).c  
Most adult-onset HD cases feature a mutated form of the protein (m-Htt) with 40–50 Qs. 
Expansions of 50 and more repeats generally cause the juvenile form of the disease (Gusella 
& MacDonald 2000). There is a strong negative correlation between the age of HD’s onset 
and the number of Qs (Gusella & MacDonald 2000). Usually, the longer is the polyQ tract, 
the earlier is the age of the onset (Ross 1995; Gusella & MacDonald 2000). However, for a 
                                                 
bIn 2008, the first Htt orthologs multi-alignment provides evidence that the polyQ is an ancient acquisition 
of Htt (Tartari et al. 2008). Its appearance dates back to sea urchin in which a NHQQ sequence is present, 
which consists of a group of four hydrophilic amino acids that can be considered bio-chemically 
comparable to the four glutamines (QQQQ) found in fish, amphibians, and birds (Tartari et al. 2008). The 
polyQ has then expanded gradually in mammals to become the longest and most polymorphic polyQ in 
humans (Tartari et al. 2008). One possible hypothesis is that wild-type Htt function, during development, 
may arise from the binding of different sets of interactors: many proteins in the cells contain a polyQ tract, 
in particular transcription factors and transcriptional regulators (Cha 2007). 
cRepeats between 27 and 35 are rare and are not associated with disease. However, they are meiotically 
unstable and can expand into the disease range of 36 and above, when transmitted through the paternal 
line. Incomplete penetrance has been observed in individuals with 36– 41 repeats, but the estimates of 
penetrance for this group are imprecise. 
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given Q length there is a large variation in the age of onset, and the number of Qs by itself 
has poor predictive power on the age of HD’s onset (Imarisio et al. 2008). m-Htt abnormally 
interacts with other proteins (Sapp et al. 1999) and causes brain damage (Borrell-Pages et al. 
2006) producing oxidative stress, excitotoxic processes and metabolism deregulation 
(Grunewald & Beal 1999; Sapp et al. 1999).d  
 
Fig. 1. Htt and Ex1: A) Scheme of Ex1 regions with B) the corresponding primary sequence; 
C) Proposed model of Htt. The HEAT domain is magnified. HEAT repeats are ∼40 amino-
acid domains, which fold in two anti-parallel α-helices forming a hairpin (Palidwor et al. 
2009). Htt features 16 of these repeats (Andrade & Bork 1995; Palidwor et al. 2009; Li et al. 
2006) organized in 4 clusters (Tartari et al. 2008). 
                                                 
dThe expression of long Q tracts alone, in the context of an N-terminal fragment or full-length Htt 
protein was shown to disrupt a wide variety of biological functions in cells and model organisms 
(Johnson and Davidson 2010; Mangiarini et al. 1996; Zoghbi and Orr 2000). 
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Neuronal intra-nuclear and intra-cytoplasmic inclusions rich in polyQs are the pathological 
hallmarks of HD (Davies et al. 1997; Trottier et al. 1995). Inclusions are believed to be toxic 
since they can provoke a physical block of axonal transport between the cell body and the 
synaptic terminal as well as the recruitment of other polyQ-containing proteins, mainly 
transcription factors. These latter, interacting with m-Htt, may lose their physiological 
function, leading to cell death (Gunawardena et al. 2003; Lee et al. 2004; Li et al. 2001; Parker 
et al. 2001). However, inclusions may also result from an attempt of the cells to 
proteolytically degrade or inactivate m-Htt (Kuemmerle et al. 1999; Saudou et al. 1998). This 
alternative proposal is supported by the fact that cells forming Htt inclusions have an 
improved survival with respect to those not forming them (Arrasate et al. 2004). 
Accordingly, there is little correlation between inclusions burden and the areas of the brain 
most affected in HD (Gutekunst et al. 1999; Kuemmerle et al. 1999). The formation of polyQ 
rich inclusions proceeds through steps that generate different aggregated species, whose 
populations and stabilities may increase with polyQ length (Bulone et al. 2006). Among 
these different species are the nuclei, the oligomers, the protofibrils and, finally, the large 
fibers, which form the microscopic aggregates found in neurons (Ross & Poirier 2004). 
Unfortunately, the exact degree of toxicity of each species is not known.  
Few information is available for protofibrils and fibers (Zuccato et al. 2010), while several 
efforts were been done to characterize oligomeric species. Indeed, oligomers may be highly 
reactive toward cellular environment because they have a large surface area with respect to 
volume ratios, as compared with larger inclusions. This reactivity may be correlated with 
toxicity (Ross & Poirier 2004; Ross & Poirier 2005; Nagai et al. 2007; Truant et al. 2008). 
Recent studies highlighted that the oligomers could be formed in several ways such as via 
N-terminal or direct polyQ interactions (Legleiter et al. 2010; Olshina et al. 2010; Ramdzan et 
al. 2010). However, the oligomers may also not be the pathway thought which the formation 
of polyQ larger inclusions takes place (Ross & Tabrizi 2011). 
1.3 Role of the flanking regions 
N17 and polyP modulate toxicity of m-Htt Ex1 (Truant et al. 2008; Atwal et al. 2007; 
Bhattacharyya et al. 2005).e Indeed, deletion of the proline-rich (P-rich) region in m-Ex1 
fragments greatly increases their toxicity in yeast. These m-Ex1 fragments are otherwise 
innocuous (Dehay & Bertolotti 2006). Therefore, the P-rich region appears to be protective 
against the effects of expanded polyQ (Bhattacharyya et al. 2005).  
N17, present in all mouse models of HD, was shown to modulate the toxicity of m-Htt in a 
structure-dependent manner (Truant et al. 2008; Atwal et al. 2007). A single point mutation 
in the middle of N17 was shown to disrupt the possibility to obtain a helical structure, 
completely abrogating any visible aggregates of m-Htt (Truant et al. 2008; Atwal et al. 2007). 
Indeed, the initial phases of the aggregation process seem to be accelerated by hydrophobic 
                                                 
eAlso sequences exogenous to Ex1 modulate aggregation. In the yeast toxicity model, the positioning of 
flag-tags on the expression constructs modulate toxicity and the nature of aggregated protein 
(Duennwald et al. 2006). Another group observed modulation of polyQ aggregation by the use of 
structured chimeras with the cellular retinoic-acid binding protein in E. coli (Ignatova et al. 2007). 
Finally, it has shown that also some purification tag, such as the glutathione S-transferase fusion does 
affect the aggregation dynamics of polyQ (Perutz 1994). 
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interactions within an amphipathic α-helical structure of N17 (Thakur et al. 2009). 
Accordingly, the deletion of this region strongly reduces polyQ aggregation in vitro (Thakur 
et al. 2009). These results suggest that the regions outside the polyQ tract may interact with 
each other, influencing aggregation (Truant et al. 2008; Zuccato et al. 2010).  
The first proposed polyQ aggregation pathway was mediated only by aggregation of the 
polyQ stretches (Bates 2003; Ross & Poirier 2004; Wanker 2000). It displayed the kinetics of 
nucleated-growth polymerization with a prolonged lag-phase required to form an 
aggregation nucleus, followed by a fast extension phase during which additional polyQ 
monomers rapidly joined the growing aggregate. 
The second, recently proposed, aggregation pathway comes from Wetzel’s group (Kar et al. 
2011; Thakur et al. 2009). This depends mainly on N17 and involves several intermediates. 
In particular, the aggregation process may be characterized by the formation of oligomers 
having N17 in their core and polyQ sequences exposed on the surface. As the polyQ length 
increases, the structure decompacts and oligomers or protofibrils rearrange into amyloid-
like structures capable of rapidly propagating via monomer addition (Kar et al. 2011; 
Thakur et al. 2009). The importance of the flanking regions suggests other therapeutic 
targets for polyQ-mediated neurodegeneration related to N17 or polyP, rather than polyQ 
itself.  
2. Computational studies of Huntington Disease  
In the following paragraph we provide an overview of the computational studies present in 
the literature carried out on the different aspects of HD such as the structure of the 
oligomers, the factors driving the formation and determining the thermodynamic stability of 
amyloidogenic aggregates and the role of the flanking regions on aggregation mechanism. 
All these studies are grouped on the basis of the topic and of the computational methods 
employed to address them.  
2.1 Structural models of polyQ oligomers — Atomistic simulations 
Many aspects of the HD’s onset mechanism could be elucidated obtaining structural 
information at atomistic level on polyQ aggregates. However, detailed structural 
information are difficult to obtain experimentally as short wild-type polyQ tracts are 
insoluble at the high concentrations required for crystallographic or NMR studies (Truant et 
al. 2008).f In contrast, structural information at atomic level of resolution can be provided by 
computational approaches (Moroni et al. 2009; Miller et al. 2010). Simulations, in fact, can 
offer insights into structural and dynamical properties of polyQ peptides of different 
lengths, shapes and oligomeric states. Computational studies of neurodegenerative diseases 
can be carried out via classical molecular dynamics (MD) (Miller et al. 2010; Ma & Nussinov 
2006). In this method, the atoms move according to the Newton’s law on a predefined 
                                                 
fA simple search within the PDB (http://www.rcsb.org/) reveals that polyQ tracts present in a variety 
of normal cellular proteins are annotated as ‘unstructured’ or have to be removed to facilitate 
crystallization (Truant et al. 2008). Only one structure exists of the N-terminal part of Htt with 17Qs, 
obtained by a fusion with maltose-binding protein. It features polyQ stretch that can adopt an ǂ-helical, 
random-coil, or an extended-loop conformation (Kim et al. 2009). 
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potential energy surface. Namely, interatomic interactions are described via empirical force 
fields. However, MD simulations in explicit water allow accessing a time scale limited to 
hundreds of ns. Thus, to simulate relevant biological processes, occurring on longer time 
scales, they have to be combined with enhanced sampling computational techniques (Christ 
et al 2010; Laio & Gervasio 2008) or it is, otherwise, necessary to use simplified interaction 
potentials (Ma & Nussinov 2006; Tozzini 2010; Miller et al. 2010). 
Several structural models of the aggregated polyQ units were proposed with geometries 
compatible with available experimental information (electron microscopy and X-ray data). 
These models were based on Perutz’s suggestion that Q side chains, being similar to the 
amino acid backbone units, could establish an H-bond network (Perutz 1999; Perutz 1994). 
In fact, Perutz, initially interpreted the X-ray diffraction data of polyQ aggregates as a polar 
zipper model, and later reinterpreted them as a circular฀β-helix model in which polyQ tracts 
can form turns composed by 20 res, with the Q side chains alternatively inside and outside 
the water filled nanotube (Fig. 2). According to this model, polyQ aggregates would be 
stabilized by H-bond interactions between main and side chain atoms (Fig. 2). In fact, the β-
sheets were proposed to be antiparallel so that an amine group of one side chain could H-
bond with the carbonyl group of the side chain belonging to the following turn (Esposito et 
al. 2008). Consistent with these X-ray diffraction data is also triangular β-helix model (Stork 
et al. 2005; Raetz & Roderick 1995), which is formed by turns of 16 residues, and the Atkins’s 
model, in which the H-bond network of the Q side chains allows for high-density packing 
(Sikorski & Atkins 2005). Although several models were proposed for the polyQ aggregates, 
this issue is highly debated and it is still not clear which is the most common structure 
present in the aggregates. 
Many studies of the proposed models for the polyQ aggregates were preformed via 
classical MD simulations (Perutz 1994; Perutz et al. 2002; Sikorski & Atkins 2005; Sunde & 
Blake 1997; Sunde et al. 1997; Sharma et al. 2005), providing valuable insights on their 
stabilities (Sikorski & Atkins 2005; Esposito et al. 2008; Stork et al. 2005; Armen et al. 2005; 
Finke et al. 2004; Finke & Onuchic 2004; Marchut & Hall 2006, 2006, 2007; Merlino et al. 
2006; Zanuy et al. 2006; Ogawa et al. 2008). Among these, several studies investigated the 
dependence of the structural stability of the circular β-helix, as well as of other possible 
structures, on the Q length (Stork et al. 2005; Merlino et al. 2006; Ogawa et al. 2008; 
Rossetti et al. 2008; Hajime et al. 2008; Khare et al. 2005), leading sometimes to conflicting 
views. For example classical MD studies showed that β-helices with three turns were 
unstable with circular geometries, being, instead, stable in a triangular β-helix shape. 
Moreover, these studies pointed out that two-coiled triangular polyQ β-helices, which 
were individually unstable, became, instead, stable upon dimerization. This suggested 
that the formation of the initial aggregation seed of huntingtin amyloids requires dimers 
of at least 36 Qs (Stork et al. 2005). A subsequent study verified the stability of the circular 
β-helix model by performing MD simulations on polyQ fragments of different lengths. 
The results pointed out that circular β-helix models maintained a regular structure during 
the MD run, only when containing more than 40 Qs (Merlino et al. 2006). Moreover, a 
different MD study showed that the stability of the circular β-helix structure increased 
with an increasing number of Q, reaching the maximal stability above 30 Qs (Ogawa et al. 
2008). In contrast to these computational results, annular units smaller than the circular β-
helix model were detected experimentally and confirmed by other computational studies 
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(Marchut & Hall 2006a, 2006b, 2007; Papaleo & Invernizzi 2011). A more recent MD study 
proposed a systematic investigation of structural characteristic of polyQ strands in the 
early stage of nucleation, considering left handed circular, right handed rectangular, left 
and right handed triangular β-helices of different lengths (Zhou et al. 2011). These 
simulations showed that left handed triangular and right handed rectangular 
conformations were stable when they had at least three turns, preserving a high degree of 
the β-sheet content during the simulation. The stability of the systems increased with an 
increasing number of rungs, but it was insensitive to the number of Qs in each polyQ 
fragment (Zhou et al. 2011). Classical MD simulations were also performed for the cross-
β-spine steric zipper model (Esposito et al. 2008), a motif found for the GNNQQNY 
peptide, an heptapetide present in the N-terminal prion-determining domain of the yeast 
protein Sup35. The simulations revealed that this kind of polyQ assemblies were very 
stable. In fact, the H-bonds between either parallel or antiparallel β-sheets, greatly 
affected the high stability of these structures, with a large contribution coming from the Q 
side chains H-bonds.  
 
Fig. 2. Molecular view of circular β-helix structure with particular of: A) external and  
B) internal H-bond network. A similar H-bond network is observed also for the triangular β-
helix structure. 
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In summary, all these computational studies suggested that several polymorphic forms of 
polyQ oligomers can exist and that all of them, when present as monomers, become more 
stable with an increasing number of Qs or upon aggregation with other polyQ tracts. The 
polymorphism of polyQ structures may possibly result in different pathways leading to the 
formation of toxic oligomers and fibrils.  
2.2 Cooperativity of polyQ H-bonds — ab inito and Hybrid QM/MM simulations 
Computer simulations can also help in elucidating the role of the peculiar electronic 
properties of the Q side chains in the formation of polyQ the aggregates. β-sheets are 
ubiquitous in protein structures and in aggregates of amyloidogenic proteins (Tartari et al. 
2008). Thus, understanding the electronic factors contributing to the thermodynamic 
stability of β-sheets is of fundamental importance in neurodegeneration (Rossetti et al. 2010). 
In the past, several research groups tried to address experimentally and computationally 
whether the formation of β-sheets is cooperative. Cooperativity in H-bonding exists from a 
structural and from an energetic point of view when the strength of H-bonds and the 
thermodynamic stability of the H-bonding structures, respectively, increase non-linearly 
with an increasing number of H-bonds. From an electronic point of view H-bond 
cooperativity depends on the polarization of the electronic clouds of adjacent molecules or 
strands. If, polarization effects are present, a rearrangement of electronic structure takes 
place. This aspect is clearly not accounted in force field calculations, which are grounded on 
predefined parameters of the potential energy. Thus, despite the successes of classical MD 
simulations in the study of neurodegenerative diseases, there are cases in which the use of 
effective potentials may be not accurate enough. In these cases a more sophisticated 
computational approach is provided by static or dynamics ab initio calculations, typically 
based on Density Functional Theory (DFT). In static DFT calculations the electronic 
structure problem is solved parametrically for nuclear configurations generated by 
minimization schemes. Instead, in dynamic DFT calculations the atoms move according to 
the Newton’s law on a potential energy surface, which is evaluated from electronic structure 
calculations (Spiegel & Magistrato 2006; Carloni et al. 2002). Clearly, ab initio schemes, 
requiring to solve the electronic structure problem for different nuclear configurations, are 
much more computationally demanding than classical MD, limiting the size of the systems 
studied to hundreds of atoms and the time scale accessible to ab initio MD to tens of ps 
(Carloni et al. 2002). Since biological systems treated in their environment comprise several 
hundreds of thousands of atoms, they are clearly too large to be treated with a full ab initio 
description. An alternative approach to treat these systems relies on hybrid quantum-
classical (QM/MM) MD simulations. The QM/MM MD approach combines classical with ab 
initio MD. In this approach the system under investigation is divided into two different 
regions, allowing to concentrate the computational efforts of the electronic structure 
calculations (QM part) to the part in which the force field can fail. The rest of the system is, 
instead, treated with empirical force fields in a computationally more efficient manner 
(Spiegel & Magistrato 2006). This allows to extend the size of the systems studied to 
hundreds of thousands of atoms, although the computational cost of the QM part still limits 
the time scale accessible to few tens of ps.  
The role of cooperative effect (CE) of H-bonds between different strands of amyloidogenic 
aggregates was investigated by performing static DFT calculations on the known molecular 
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structure of the heptameric peptide GNNQQNY. This study showed that the strength of H-
bonds between layers of fibrils increased nonlinearly up to four layers. Moreover, it showed 
that the H-bonding interactions within the β-sheets of the amyloid structure were 
cooperative, with contributions to the binding energy from several layers away within the 
fibril (Tsemekhman et al. 2007). Other studies carried out on polyAlanine (A), polySerine, 
polyValine homo-polymers showed that H-bonding and dipole–dipole interactions were 
strengthened through CEs, contributing to the stability of the secondary structures (Horvath 
et al. 2004, 2005; Varga & Kovács 2005; Improta & Barone 2004; Improta et al. 2001; Improta 
et al. 2001; Wieczorek & Dannenberg 2003). In these studies the influence of the side chains 
on the thermodynamic stability of the investigated structures was also verified. These 
results highlighted the presence of cooperativity in the C=O..H-N H-bond, which was an 
important source of long-range interactions (Horvath et al. 2005). Instead, DFT calculations 
performed on polyGlycine (G) of different lengths and conformations showed the influence 
of long-range effects on the stability of different conformers (Improta & Barone 2004; 
Improta et al. 2001; Improta et al. 2001). Moreover, long-range interactions were shown to 
contribute considerably to the stability of the β-sheet structures, with appreciable effects on 
the molecular geometry. It was also shown that the H-bond length was very sensitive to 
long-range interactions (Horvath et al. 2004, 2005). Finally, a DFT study carried out also on 
polyG peptides showed that repeating H-bonds either in parallel and antiparallel β-sheets 
were not cooperative in terms of enthalpy contribution in the direction parallel to strand 
elongation. CEs existed, instead, in the perpendicular direction and they depended on the 
number of residues in each strand (Zhao & Wu 2002). Thus, all these studies suggested that 
H-bond CEs exist in homopolypeptides in different conformations, including the β-sheet 
structure. Since the Q side chain resembles an animoacid backbone, it is likely that CEs will 
greatly contribute to H-bond cooperativity and to the thermodynamic stabilization of the 
polyQ β-sheets. This aspect was addressed recently by performing ab initio and QM/MM 
MD calculations (Rossetti et al. 2010). 
2.3 Aggregation properties and the role of exon-1- coarse grain models and enhanced 
sampling techniques  
The details of molecular mechanism leading from the association of monomeric polyQs to 
the formation of mature fibrils remain highly debated. As mentioned above, Wetzel at al. 
suggested initially a nucleated grow polymerization model based only on the polyQ 
peptides to connect the disordered monomers to the highly ordered β-sheet structures 
present in the fibrils (Papaleo & Invernizzi 2011).  
Several computational studies were carried out to shed light on the aggregation properties 
of polyQ chains, on the formation of the initial aggregation nucleus and on the role of the 
regions flanking the polyQ tract in m-Ex1 (Papaleo & Invernizzi 2011). A common 
methodology employed in these studies was the use of coarse grain (CG) models, in which 
groups of atoms are described as a single bead (Tozzini 2010). In the simplest model only 
three types of beads, namely hydrophobic, hydrophilic and neutral, are considered. Other 
CG models instead have special terms to account for H-bond formation, which is crucial for 
aggregation (Ma & Nussinov 2006). CG methods usually allow to extend the time scale 
accessible to MD simulations, loosing, at the same time, the accuracy of an atomistic 
description. Sometimes atomistic simulations with the use of implicit solvent models give an 
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alternative to the CG models. However, an explicit treatment of the solvent is of crucial 
importance for a correct characterization of the folding and of the aggregation properties of 
polypeptides (Papaleo & Invernizzi 2011). Conversely, atomistic simulations can be used in 
combination with methods, which allow to extend the time scale of the simulations, 
enhancing the sampling of the underlying free energy surface (Laio & Gervasio 2008; Christ 
et al. 2010; Biarnes et al. 2011; Sugita & Okamoto 2000; Bussi et al. 2006). These latter warrant 
the accuracy of the atomistic description, but they are computationally very demanding and, 
in most cases, not yet at the stage of being able to simulate the folding and/or the 
aggregation of peptides of the biologically relevant lengths (Rohrig et al. 2006; Miller et al. 
2010). Among the aggregation studies carried out so far for HD, a force filed based monte 
carlo simulation study in implicit solvent (Vitalis et al. 2009) investigated the free energy 
cost associated with the formation of ordered β-sheet structures in dependence an increasing 
number of Qs in the single monomer (Vitalis et al. 2009). This work reported the free energy 
costs to form structures with a high β-sheet content consistent with literature data. 
However, an increase of this free energy cost with an increasing chain length was observed, 
in contrast to previous interpretation of kinetic data. Moreover, the authors suggested that 
β-sheet formation may be an attribute of peptide-rich phases characterized by high 
molecular weight aggregates rather than monomers or oligomers (Vitalis et al. 2009).  
Discrete Molecular Dynamics (DMD), an efficient MD method based on a simplified 
interparticle potential (Miller et al. 2010), was employed to show that the cooperativity in 
the folding of a chimeric monomer (composed by Chymotrypsin inhibitor 2 with an inserted 
polyQ repeat) decreased for peptides with polyQ lengths above the pathogenic threshold. 
Moreover, it was demonstrated that the dominant mode for dimer formation was inter Qs 
H-bonding (Barton et al. 2007). The aggregation of model polyQ peptides was also 
investigated via MD simulations with a simplified model of polyQ (Marchut & Hall 2006a, 
2006b, 2007). This model accounted for the most important types of intra- and inter-
molecular interactions, namely H-bond and hydrophobic interactions, allowing the folding 
process to take place within the time scale of the simulation (Marchut & Hall 2007). In this 
study the folding of isolated polyQ tracts of non-pathogenic and pathogenic lengths, and the 
folding and the aggregation of systems of polyQ peptides of various lengths were 
investigated. The isolated polyQ peptides formed some backbone–backbone H-bonds, 
although the hydrogen bond content (HBC) was markedly lower than that of an ordered β-
sheet structure. In the multi-chains simulations, instead, ordered aggregates with significant 
β-sheet and random coil characters were observed at intermediate and high temperatures, 
respectively. Interestingly, the temperature at which the peptides underwent the transition 
from amorphous to ordered aggregates and from ordered aggregates to random coils 
increased with increasing polyQ length. More recently, the aggregation of polyQ peptides of 
different lengths was addressed via replica exchange (RE) MD and a simplified force filed. 
REMD simulations combine several MD simulations at elevated temperature to generate a 
variety of conformational ensembles with a Monte Carlo like conformational selection (Bussi 
et al. 2006). Thus, this method allows to explore the conformational space of peptide 
aggregation and folding, instead of getting trapped in local minima (Sugita & Okamoto 
2000). In this work REMD was applied to study the aggregation kinetics of the polyQ 
monomers and dimers with chain lengths from 30 to 50 residues. The results showed that  
for the monomers a structural change from an฀α-helical structure to random coil occurs with 
no formation of a β-strand. For dimers, instead, starting from random coils there was the 
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initial formation of antiparallel β-sheets, of circular and of triangular β-helices, which may 
lead to the formation of toxic oligomers and fibrils (Laghaei & Mousseau 2010). 
As stated previously, the sequences flanking the polyQ tract have been recently 
demonstrated to have a key role on aggregation mechanism (Thakur et al. 2009). However, 
structural information on these segments are lacking. Thus, more recent computational 
studies employed the classical MD method in combination with enhanced sampling 
techniques to investigate the complex free energy landscape for the folding and for the 
aggregation of the N terminal region of Htt (Ex1 or N17). These studies are of crucial 
importance to understand how the misfolding and aggregation of polyQ tract(s) is affected 
by the flanking sequences. 
Classical MD studies in combination with simulated tempering and folding at home 
infrastructure were employed to study the thermodynamics of N17 (Kelley et al. 2009). In 
these simulations N17 was found to be highly helical, although adopting two different and 
seemingly stable states. The most populated state was a two-helix bundle, although a 
significant percentage of structures still assumed the conformation of a single straight helix. 
Since N17 was demonstrated to be involved in the rate-limiting step for the formation of the 
initial aggregation nucleus, two possible mechanisms for the nucleating event were 
proposed in this study. These are based on a transition between the two-helix and single-
helix state of N17 and on the interactions between the N17 and the polyQ tract (Kelley et al. 
2009). Moreover, a recent Monte Carlo simulation study, along with circular dichroism 
experiments, described the effect of N17 on polyQ conformations and intermolecular 
interactions. This study showed that N17 and polyQ domains were increasingly disordered 
as the polyQ length increased in N17-polyQs peptides. In contrast with experimental 
suggestions (Thakur et al. 2009), N17 suppressed the intrinsic propensity of the polyQ tracts 
to aggregate by forming incipient micellar structures adopted by N17 segments. Instead, 
increasing the polyQ length the degree of intermolecular association increased, becoming 
mainly governed by the associations between polyQ tracts (Williamson et al. 2010). Finally, 
a systematic DMD study, in combination with the RE method, was carried out on 
monomeric Ex1 with the full flanking regions on a variant of Ex1 missing the polyP region, 
which is hypothesized to prevent aggregation, and on an isolated polyQ peptide. For each of 
these three constructs, polyQ tracts of pathogenic and non-pathogenic lengths were 
considered. Interestingly, the study showed a correlation between the length polyQ tract 
and the probability to form a misfolded state rich in β-sheets. Furthermore, it showed that 
N17 more likely adopted a β-sheet rather than an α-helix conformation as the length of the 
polyQ tract increased. Finally, this study demonstrated that the polyP region formed polyP 
type II helices, decreasing the probability of the polyQ to form a state rich in β-sheets 
(Lakhani et al. 2010). More recently, enhanced sampling techniques were employed to 
predict the conformational properties of N17 fragments in water solution and to shed light 
on its crucial role in Htt aggregation (Kar et al. 2011). 
3. Selected applications 
In the following paragraph we present three selected examples taken from our work in 
which we explain in detail how computer simulations can be employed to address the 
different, still unclear, aspects of the HD’s onset mechanism. 
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3.1 The HD threshold and the structural stability of toxic conformers 
In this work we have addressed one of the questions lengthily debated concerning the 
polyQ length-dependent toxicity threshold. One hypothesis suggested that the length 
dependent toxicity of HD was based on a specific structural transition, occurring only when 
the polyQ tract is above 36 amino acids (structural transition hypothesis). Consistent with 
this hypothesis, an anti-polyQ monoclonal antibody was observed, which was able to 
specifically recognize the expanded toxic polyQ tracts. This suggested the existence of a 
generic conformational epitope formed only above a certain polyQ length (Trottier et al. 
1995; Kaltenbach et al. 2007; Sugaya et al. 2007). The presence of such abnormally folded 
protein, which can aggregate and form fibrillar structures, could highlight similarities 
between HD and other neurodegenerative diseases such as Alzheimer’s, Parkinson’s D, and 
prion disorders (Ross & Poirier 2004). Hence, several efforts were done for “hunting the 
elusive toxic polyQ conformer” (Trottier et al. 1995). This hypothesis was, however, 
challenged by various experimental evidences. First, polyQ fragments shorter than the 
disease threshold were also shown to aggregate, adopting similar structures to those of 
peptides longer than threshold (Klein et al. 2007; Masino et al. 2002; Bennett et al. 2002; 
Tanaka et al. 2001) and to exhibit toxicity in an eukaryote organism (Caenorhabditis elegans) 
(Morley et al. 2002). Second, it was shown that polyQ length influences the stability of the 
initial aggregation seed and that, in turn, it may affect the kinetics of its formation (Chen et 
al. 2002). The kinetics of the elongation phase is, instead, independent of the polyQ length 
(Chen et al. 2002). Furthermore, it was suggested that the toxicity of mut-Htt may be simply 
due to the fact that polyQ tracts are inherently toxic sequences, whose deleterious effects 
gradually increase with their length (Klein et al. 2007). We investigated the influence of the 
polyQ length on the structural stability of monomers and oligomers by performing atomistic 
MD simulations on different β-helical models featuring a number of Qs below and well 
beyond the disease threshold (Rossetti et al. 2008). We considered the circular (Raetz & 
Roderick 1995) and triangular β-helices (Stork et al. 2005; Perutz et al. 2002) as shapes of the 
oligomers, since these are the only models consistent with the ‘structural threshold 
hypothesis’. Thus, we studied two large monomeric models based on the circular β-helix 
(labeled as P from Perutz, who introduced this model in 2002 (Perutz et al. 2002)), and on 
the triangular β-helix model (labeled as T). This latter was constructed starting from the 
regularly shaped coils of UDP-N-acetyl glucosamine acyltransferase (Raetz & Roderick 
1995) (Protein Data Bank entry: 1LXA) (Berman 2000), and replacing each residue with a 
glutamine. The circular and triangular β-helix models contained 266 and 179 residues and 
each turn was composed by 20 and 18 Qs, respectively. Both the T and the P models were 
composed by a single polyQ chain and had a number of Qs well above that observed at 
physiological conditions. In addition, we considered different oligomeric models built 
starting from the single chain P and T systems: (i) 4 oligomers in circular β-helix 
conformation composed by 4, 3, 2, 1 monomers (each composed by 40 Qs). These were 
named PAD, PAC, PAB, PA, respectively. (ii) 4 oligomers in triangular β-helix conformation 
with respectively 4, 3, 2, 1 monomers (each composed by 36 Qs). These models were 
symbolized by TAD, TAC, TAB, TA , respectively. (iii) One oligomer in circular β-helix 
conformation composed by 8 monomers each containing 25 Qs residues. The model was 
named PAH25. (iv) Finally, we considered 4 small monomeric models in circular β-helix 
conformation composed by 25, 30, 35, 40 Qs and symbolized by P25, P30, P35, P40, respectively. 
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These models were chosen to perform a systematic study that allowed us to validate or 
discard the ‘structural threshold hypothesis’. Moreover, by varying systematically the size 
of the polyQ units in these models, and considering both the monomeric and oligomeric 
states, our calculations shed light on the dependence of the stability of β-helical structures 
upon the number of monomers. Finally, considering both the P and T helical structures, our 
findings became independent of the structural model chosen. To simplify the discussion we 
defined qualitatively the Structural Stability (SS) as a quantity which increased (i) with the 
compactness of the structure, as measured by the plots of the RMSD of backbone atoms, as 
well as the gyration radius (Rg) versus time and (ii) with the HBC, defined as the total 
number of H-bonds formed within the structural models, divided by the total number of H-
bond donor functionalities. Our MD simulations at finite temperature and in aqueous 
solution pointed out that the two different β-helix shapes influenced only the β-sheet 
content. In particular, the T helix displayed a larger number of residues in random coil 
conformation than the P one. However, the HBC as well as the SS of the two shapes were 
comparable (Fig. 3). Moreover, we demonstrated that SS did not depend on the number of 
Qs in the monomers. In fact, oligomers composed by 4 monomers of 40 Qs and by 8 
monomers of 25 Qs had similar SS. Consistent with our results an NMR study revealed no 
structural difference between aggregates formed by short and long polyQ peptides (Klein et 
al. 2007). We also showed for the first time that the SS of polyQ oligomers was not affected 
by the shape. We suggested, instead, that only the number of monomers – thus, the 
concentration in an (in vivo or in vitro) experiment - contributes to the overall stability of the 
oligomers. This may be due to the additive contribution of the single monomer in the H-
bond network formed between backbone atoms (Fig. 3).  
Conversely, the H-bonds formed between Q side-chains influenced mainly the stability of 
the single isolated monomers (Fig. 4). In fact, the isolated monomer with Q length above the 
disease threshold, P40, was characterized by a larger number of β-sheet content and HBC, 
with respect to shorter monomers (Fig. 4). This latter depended mainly on side chain H-
bonds, and thus, on the number of Qs. Therefore, if the Q length was lower than that of the 
disease threshold, the฀β-stranded monomers were unstable and, hence, they might 
aggregate with lower probability (Fig. 4), consistent with experimental findings. 
In conclusion, our data discarded the structural threshold hypothesis. However, interpreting 
our findings on the basis of the whole landscape of available experimental data (Klein et al. 
2007), we suggested that the observed length-dependent toxicity threshold may be 
explained by a faster aggregation kinetics, occurring for longer polyQ tracts. 
3.2 Hydrogen bonding cooperativity in polyQ β-sheet investigated by ab initio and 
QM/MM MD simulations 
Perutz was the first to show that the polyQ tracts may form β-sheet based structures, which 
are able to establish tighter interactions with increasing polyQ length. Therefore, the 
correlation between the strength of the polyQ chain and the strength of the interactions may 
be a key aspect at the basis of the correlation between polyQ length and severity of disease 
(Perutz 1994). Peruz suggested that this may be due to the Q side chain, which, having the 
same chemical characteristics of an amino acid backbone, can form a network of H-bonds 
involving both the main and the side chain atoms (Perutz 1994; Klein et al. 2007; Perutz & 
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Windle 2001)g. CE in H-bonding is very important for both the structure and the energetic of 
polypeptide systems. As the presence of CE was demonstrated for other homopolymers, it  
is likely that this effect may be particularly relevant in the peculiar H-bond network of  
polyQ, playing a key role in Htt/Ex1 misfolding and aggregation (Perutz 1994; Perutz & 
Windle 2001). Most of the studies carried out on the structural stability of polyQ oligomers  
 
Fig. 3. HBC in P and T series given as percentage of H-bonds in the P series (left column), in 
the T series (middle column) and in the monomeric series (right column). Blue, green and 
red histograms represent the total, the main chain and the side chain HBC, respectively. The 
solid cylinder refers to the P model and the black circles refer to monomers of 40 Qs in 
circular β-helix. The triangular cylinder refers to the T models and the black triangles refer 
to monomers of 36Qs in triangular β-helix shape. Monomers of different lengths are 
indicated with the number of Qs present in the chain.  
                                                 
gConsistently with this hypothesis, aggregates of protein are not seen in proteins expressing 
polyasparagine, an amino acid that differs from glutamine even by only one methyl group (Oma et al. 
2004). 
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Fig. 4. β-sheet (green) and random coil conformation (red) of oligomers in circular (left 
panel) and triangular (middle panel) β-helix conformations, symbolized as black circles and 
triangles, respectively (A) and of P40, P35, P30, P25 monomers (B) (right panel). Monomers of 
different lengths are indicated with the number of Qs present in the chain. On the left and 
right side of the graph in B the initial and final (after 20 nanoseconds (ns) MD) geometries of 
each monomer are shown. Water is not shown for clarity.  
were achieved by classical MD calculations, which, not dealing with electronic 
polarizability, were not suitable to characterize the presence of CE in this kind of aggregates. 
CE was investigated on other polypeptides (Tsemekhman et al. 2007; Varga & Kovács 2005; 
Horvath et al. 2004, 2005; Improta & Barone 2004; Improta et al. 2001; Improta et al. 2001; 
Zhao & Wu 2002; Wieczorek & Dannenberg 2003; Viswanathan et al. 2004; Scheiner & Kar 
2005) with the application of first principle methods. However, here we provide a summary 
of the first study in which the presence and the importance of CE in the H-bonds of Qs side 
chains was verified with DFT approaches (Rossetti et al. 2008). We performed first principles 
DFT-PBE (Benedek et al. 2005; Morozov et al. 2004; Perdew et al 1996) calculations on polyQ 
peptides of increasing complexity, assembled in parallelh β-sheets (Tsemekhman et al. 2007; 
Koch et al. 2005; Beke et al. 2006; Perczel et al. 2005). In order to carry out this study we used 
different modelsi (labeled as Nxn hereafter), which differed from each other for the number 
of strands (N=1, 2, 3, 4) and/or for the number of Qs in each strand (n=1, 2, 3, 4).i The 
resulting 16 models ranged from 29 to 320 atoms. Furthermore, to verify the contribution of 
the polyQ side chains to CE we also considered a series of models where we varied the 
initial Q side chains conformations putting them in a position in which they could not H-
                                                 
hCE turns out to be stronger in parallel ǃ-sheets (like the systems considered here) than in anti-parallel 
ones (Koch et al. 2005). 
iThe models were built using HyperChem 8.0 program (Hypercube) 
iEach polypeptide is terminated by the addition of -NCH3 and -OCCH3 groups. 
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bond with the adjacent strand and, a series of models built with polyA. Finally, to check the 
role of solvent and temperature effects on polypeptide conformation (Scheiner & Kar 2005) 
we performed 2 ps of hybrid DFT/MM MD calculations on a large a β-helix nanotube (8 
turns of 20 Qs) in aqueous solution (Perutz et al. 2002; Berendsen et al. 1995; CPMD; 2002; 
van der Spoel et al. 2005). In this case, we considered three models in which the QM part 
included the 4x4, 3x4 and 4x3 moieties.  
Although circular β-helix is only one of the possible polyQ structures (Sikorski & Atkins 
2005; Zanuy et al. 2006), we investigated it since we demonstrated by classical MD studies 
that the structural stability of the polyQ oligomers was independent from the β-sheet shape 
(Rossetti et al. 2008). In this study, in fact, we aimed at providing a qualitative description of 
CE. Quantitative predictions would, instead, require an investigation on a variety of 
proposed structures. CE on β-sheet strands may be present in patterns perpendicular to the 
peptide elongation (ㅗ฀CE) or parallel to it (||CE) (Fig. 5A). When ㅗ CE is present a decrease 
in H-bond length should be observed with an increasing number of strands. Moreover, in ∞CE 
the H-bonds at the center of the pile should be shorter than at the rim. Consistent with the 
presence of ㅗ฀CE, in all models considered the H-bond distances of both the backbone and the 
side chains decreased with an increasing number of strands. In addition, H-bond lengths 
turned out to be shorter at the center of H-bonded chains than at the rim when at least three H-
bonds were piled up in the perpendicular direction (N= 4). This feature was observed both for 
the side chains and the backbone. Interestingly, it was observed that the backbone dipoles 
along the same column (H-bond in the perpendicular direction) of β-strands had the same 
orientations (in contrast to those of the adjacent column) and could, therefore, sum up 
increasing the polarization of the systems (Zhao & Wu 2002). However, in the peculiar case of 
polyQ β-strands, the Q side chains counterbalanced this polarization, affecting the H-bonds of 
the backbone. As a result, in the columns where the H-bond dipole orientations were 
enhanced by similar side chain H-bond dipole orientations, a ㅗ CE was present. This resulted 
in a H-bond shorter at the center of the column. On the other hand, when neighboring side 
chain columns had H-bond dipoles oriented in opposite directions (with respect to the column 
considered), the inner H-bond was not the shortest of the column (Fig. 5 D and E). This 
explains why for the backbone the ㅗ฀CE, namely the fact that H-bonds are shorter at the 
center of the pile and not at the rim, was visible only by tacking averages (Fig 5D).  
A different type of CE is that parallel to peptide elongation (||CE). When ||CE is present, a 
shortening of the central H-bond lengths between two adjacent strands takes place. This is 
usually not present in β-sheets due to the alternative orientation of backbone H-bond 
dipoles along the strands. However, the dipoles associated with the Q side chains added up 
in a coherent way for the central H-bonds between two strands (Fig. 5E). This occurred at 
position 2 in N × 2 series, at positions 2 and 3 in N× 3 series and at positions 2, 3, and 4 in N 
× 4 series. Thus, these H-bonds were shorter than those of the rim. As expected, in the 
calculations in which the side chains were impaired of H-bonding or Qs were replaced by 
As, the ||CE was not observed. QM/MM MD calculations qualitatively reproduced the H-
bonds trends of the corresponding in vacuo models. However, in these simulations H-bond 
lengths were larger and the side chains formed mostly H-bonds with the solvent. These 
differences were probably due to the presence of the solvent and to temperature effects, 
which were completely neglected in the in vacuo calculations. These calculations suggested 
that environmental effects influence only the magnitude of CE in H-bonding, while the 
qualitative trend was the same of that found in the in vacuo calculations. 
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Fig. 5. Cooperative Effect - A) Definition of CE in H-bonds parallel (∥) and perpendicular 
(⊥) directions to peptides elongation. B)-C) Structural aspects of CE: B) Backbone CE (⊥CE): 
Mean values of H-bond lengths of the backbone atoms versus the number of strands for 
each series of n Qs. C) Side chains CE (⊥CE): Mean values of H-bond lengths for the side 
chain atoms versus the number of strands for each series of n Q. D)-E) ⊥CE in system 4x4. 
D) In the histograms: H-bond length of backbone for different positions inside each strand 
as a function of the position across the different strands. Color of the histogram corresponds 
to the H-bonds circled on the left picture of B. The black line connects the mean values over 
the rows. E) Orientation of dipoles associated with the H-bonds for the 4x4 system. 
Consistent with these results, in the simulations in which the Q side chains were impaired to 
H-bond and in the models in which the Qs were replaced by As, the H-bond at the center of 
the polyQ chain was longer than at the rim. The H-bond lengths, instead, continued to 
decrease with the number of piled strands even in these systems.  
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Finally, we also calculated the stabilization energy associated with the formation of H-bonds 
between the different strands of the systems in vacuo. To this end we defined the 
stabilization energy per strand (∆EN) as the energy associated with the addition of the Nth Q 
strand to the QN-1 strands (EN×n), minus the formation energy of the N isolated strand 
(∆EN=E N×n - N·E1×n ). In this definition, EN×n is the energy of a system containing N strands 
and belonging to the n series; while E1×n is the energy associated with an isolated strand 
containing n Qs. In practice this is the energy of a strand containing n Qs isolated from long- 
range effects. We also introduced the stabilization energy per H-bond (∆EHB) as ∆EN divided 
by the number of H-bonds (nHB) in each system (∆EHB =∆EN/nHB ).  
Our study showed that ∆EHB decreased nonlinearly with the number of strands (Fig. 6). 
∆EHB ranged from -5.0 kcal/mol in the smallest system to -6.5 kcal/mol in the larger system, 
suggesting that a CE existed and that for the present systems this was at most of 1.5 
kcal/mol per H-bond. Clearly this stabilization energy was smaller for models containing A 
residues and with Qs side chains rotated to impair H-bonding. 
 
Fig. 6. Cooperative effect calculated as stabilization energy per H-bond. 
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3.3 Conformation of N17 in aqueous solution investigated by bias-exchange 
metadynamics 
As stated in the introduction, recently, in vivo (Truant et al. 2008; Duennwald et al. 2006; 
Aiken et al. 2009), in cell (Ignatova et al. 2007; Cornett et al. 2005; Lakhani et al. 2010), in vitro 
(Rockabrand et al. 2007; Kim et al. 2009; Williamson et al. 2010) and in silico (Lakhani et al. 
2010) studies showed that N17 modulates Htt fibrillation. This might arise by a variety of 
mechanisms, including changes in subcellular localization, nucleation of aggregation 
and/or interaction with cellular partners (Truant et al. 2008).  
Understanding the influence of N17 on the aggregation mechanisms of polyQ in HD highly 
depends on structural information. Different spectroscopic techniques such as NMR (Thakur 
et al. 2009), CD (Thakur et al. 2009; Williamson et al. 2010) and FRET (Thakur et al. 2009) 
showed that N17 in aqueous solution adopts predominantly a random-coil structure with 
transient helical conformations (Thakur et al. 2009). Thus, N17 in solution can exist in 
equilibrium between different conformations. As these experimental techniques can provide 
only information on averages between the populations of different conformers, the secondary 
and the tertiary structure contents of the different N17 conformers remain not known. In this 
selected example (Rossetti G 2011) the Bias Exchange Metadynamics (BEM) was adopted to 
describe the thermodynamics and the kinetics of N17 in aqueous solution and at room 
temperature (Piana & Laio 2007). The BEM method relies on a combination of metadynamics 
and replica exchange. (Piana & Laio 2007; Laio & Gervasio 2008; Laio & Parrinello 2002). 
Metadynamics is a powerful algorithm used for accelerating rare events. In this scheme the 
system is described by a set of collective variables (CVs) and its normal evolution in the space 
of the CVs is biased by a history-dependent potential that forces the system to escape from 
local minima. This potential is, later, used to reconstruct the underlying free energy surface. 
Metadynamics, however, is effective only to explore few reaction coordinates as its 
performance decreases enormously with an increasing number of CVs. Typically, RE method 
is performed between replica of the system at different temperature as this latter is adopted to 
enhance the phase-space exploration (Piana et al. 2008; Sugita & Okamoto 2000). An example 
of RE metadynamics exists, in which a metadynamics run is performed in replicas of the 
system at different temperature (Bussi et al. 2006). However, in BEM exchanges are performed 
between replicas of the system at the same temperature, but using different CVs. This allows 
to extend the metadynamics approach to a virtually unlimited number of variables, becoming 
very effective for protein folding (Marinelli et al. 2009). 
In this study BEM was employed to predict the free energy landscape of N17k in aqueous 
solution (Rossetti et al. 2008).j Our results showed that N17 populated four main kinetic 
basins, which interconverted on the second time-scale.l In each basin these were several 
possible clusters and an attractor, which was the lowest free energy cluster of the basin 
(Rossetti et al. 2011). The most populated basin (about 75%) was a random coil, with an 
extended flat exposed hydrophobic surface (B2, in Fig. 7). The latter may be crucial for the  
                                                 
kN17’s extended coil conformation was built with the Modeller 9v8 program (Sánchez and Sali 1997). 
The D and K residues were considered to be in their ionized state. 
jThe first three (CV1, CV2, CV3) count the number of hydrophobic contacts, of C contacts, and of 
backbone hydrogen bonds. CV4 and CV5 monitor the helical content in the whole and central part of the 
peptide. CV6 is the dihedral correlation between successive dihedrals. 
lThe free energy of each cluster is estimated by a weighted-histogram approach (Kumar et al. 1992).  
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role of N17 in Htt oligomerization because such surface may create a hydrophobic seed 
around which the flanking polyQ tract can collapse (Truant et al. 2008; Ross & Tabrizi 2011; 
Ross et al. 2003) and promote hydrophobic-force driven associations between Htt N-
terminal fragments (Thakur et al. 2009; Colby et al. 2004; Angeli et al. 2010; Tam et al. 2009). 
The other significantly populated basins, B1 and B3 (Fig. 7) assumed an amphipathic helical 
conformation, from residues 1 to 11 and from 1 to 7, respectively. Such conformation may  
 
Fig. 7. The four basins (B1-B4) of N17 in aqueous solution. B1-B4 are characterized by their 
population and by their attractor. This latter is defined as the cluster with lowest free energy 
in the basin. Only the attractors’ structures and their correspondent views of the 
hydrophobic side chain distribution are shown for clarity. The attractors’ structures of B1 
are colored in red, those of B2 in blue, those of B3 in yellow and those of B4 in grey. The 
calculated interconversion rates along with their corresponding statistical errors are 
reported. Dotted arrows are used for rates > 2 ms. 
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Modification 
Q 
tract
In 
vivo
In 
cell
In 
vitro
Helix 
Propensity
Hydro 
phobicity
SS pred: secondary structure prediction 
Burial_25: burial, less than 25% 
solvent accesibility 
Burial 5: burial, less than 5% exposure 
Reliability of prediction accuracy, 
ranges from 0 to 9, bigger is better. 
MATLEKLMKAFESLKSF - - - - 4.36 0.05 
Sequence : MATLEKLMKAFESLKSF 
SS pred : -
HHHHHHHHHHHHHHHH 
Burial_25 : ---B--BB-BB--B--B 
Burial_5 : ------B---------- 
Reliability: 73799999999999998 
MATAAAAAAAFESLKSF
(Tam et al. 2009) 103 ! - ! 3.06 -0.09 
Sequence : 
MATAAAAAAAFESLKSF 
SS pred : --
HHHHHHHHHHHHHHH 
Burial_25 : ---B--BB-BB--B--B 
Burial_5 : ----------------- 
Reliability: 98489999999999998 
MATLEKPMPAFESLKSF
(Tam et al. 2009) 103 - - ! 0.22 -0.02 
Sequence : MATLEKPMPAFESLKSF 
SS pred : ----------HHHHHHH 
Burial_25 : ---B---B-BB--B--B 
Burial_5 : ----------------- 
Reliability: 99846777746899998 
Polar to A 
MATLAALMAAFESLKSF
(Tam et al. 2009) 
103 ↓ - ↓ 6.01 0.10 
Sequence : MATLAALMAAFESLKSF 
SS pred : -
HHHHHHHHHHHHHHHH 
Burial_25 : ---BBBBBBBB--B--B 
Burial_5 : ------B---------- 
Reliability: 73799999999999998 
Non polar to A 
MATAEKAAKAFESLKSF
(Tam et al. 2009) 
103 ! - ↓ 2.26 -0.14 
Sequence : MATAEKAAKAFESLKSF 
SS pred : ---
HHHHHHHHHHHHHH 
Burial_25 : ---B--BB-BB--B--B 
Burial_5 : ----------------- 
Reliability: 99768999999999998 
MATLEKLMKAFEDLKDF
(Gu et al. 2009) 
97 ↓ - ↓ 4.31 -0.02 
Sequence : 
MATLEKLMKAFEDLKDF 
SS pred : -
HHHHHHHHHHHHHHHH 
Burial_25 : ---B--BB-BB--B--B 
Burial_5 : ------B---------- 
Reliability: 73799999999999987 
MAALEKLMKAFESLKSF 
(Aiken et al. 2009) 
46 ↓ ↓ - 6.26 0.04 
Sequence : MAALEKLMKAFESLKSF 
SS pred : --
HHHHHHHHHHHHHHH 
Burial_25 : ---B--BB-BB--B--B 
Burial_5 : ------B---------- 
Reliability: 70899999999999987 
↓ = decrease; ! = block; H=helix ; B = buried 
Table 1. Bioinformatic calculations on N17. Calculated (Improta et al. 2001) helix propensity, 
hydrophobicity and number of buried residues of N17 and non-amyloidogenic mutants. In 
all calculations, pH, temperature and ionic strength were assumed to be the same as in the 
calculations, namely 7, 300K, 0.1M. 
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facilitate the binding on N17's target surface. This was consistent with the proposal that N17 
assumes a helical fold by binding to a variety of cellular partners (Thakur et al. 2009; Colby 
et al. 2004; Angeli et al. 2010; Tam et al. 2009). This aspect, in turn, may have an impact on 
the formation of fibrils (Tam et al. 2009; Gu et al. 2009). The last basin B4 was characterized, 
instead, by a very small population and assumed a globular compact coiled structure. A 
variety of mutants of N17 are non-amyloidogenic (Tam et al. 2009; Gu et al. 2009). As for 
most of them, the mutation changes the nature of the residue from apolar to polar or vice 
versa, the result of the mutation is, probably, a reduction of the large content of amphiphatic 
conformations of N17 (Tam et al. 2009; Gu et al. 2009).m Consistently, the calculated folding 
propensity of these mutants differed significantly from that of N17 (Tab. 1). This hold true 
even if only a single point mutation was introduced (the N17(T3A) peptide) (Tam et al. 2009; 
Gu et al. 2009). In conclusion, changes in the relative population of the different basins 
induced by a change of amphiphaty may substantially affect the propensity of N17 mutants 
to form fibrils as observed experimentally (Rossetti et al. 2011). 
4. Conclusions and perspectives 
Our review clearly remarks the importance of computer simulations in complementing and 
interpreting experimental findings in neurodegenerative diseases. However, although 
computer simulations techniques are becoming more and more powerful to investigate 
these biological problems and the computer power continues to increase enormously, 
several aspects still limit the effective application of computational methods to a detailed 
understanding of the polyQ aggregation mechanism (Papaleo & Invernizzi 2011). The 
limited time scale accessible to full atomistic simulations requires the use of enhanced 
sampling algorithms to explore the conformational space of the folding and of the 
aggregation of Htt fragments, or to get insights into the physico-chemical determinants at 
the basis of this mechanism. However, these computational techniques are very demanding 
from the computational point of view and not yet capable of simulating the aggregation of 
long biologically relevant peptides. CG models may be suitable to study larger systems and 
to explore longer time scale than force filed based MD. However, they are lack of an 
atomistic description, which may be crucial to correctly describe the complex aggregation 
processes at the basis of neurodegenerative diseases. In this respect the development of 
accurate multiscale approaches based on a combination of CG and force field methods may 
be useful to overcome the limitations of both methodologies (Moroni et al. 2009; Tozzini 
2010; Neri et al. 2005). From the experimental point of view, instead, limitations to a 
complete understanding of HD’s onset mechanism are given by the lack of the 
crystallographic structure of the entire Htt protein, as well as by the lack of a detailed 
mapping of its interacting partners proteins. This latter aspect is becoming to be addressed 
both experimentally and computationally (Angeli et al. 2010; Rossetti et al. 2011). Moreover, 
theoretical and experimental studies demonstrated that several different aggregation 
pathways exist, resulting in different oligomeric and fibrillar structures of comparable 
stabilities. Probably, the dominant morphology of the aggregates is determined by the 
species having the lowest barrier to form the initial nucleation seed, rather than the largest 
                                                 
mThe helix propensity, hydrophobicity and number of buried residues of N17 as well as those of the 
mutants in Tab 1 were estimated using the AGADIR ((Lacroix, et al. 1998) at http://agadir.crg.es/), 
PEPINFO (Sweet and Eisenberg 1983) at http://emboss.sourceforge.net/ and JPRED3 (Cole et al. 2008) 
at http://www.compbio.dundee.ac.uk/, respectively. 
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thermodynamic stability. However, the relative importance of kinetic and thermodynamics 
factors in amyloids grow is still a highly debated issue (Papaleo & Invernizzi 2011). Due to 
the increased potentialities of both experimental and computational approaches a 
synergistic effort should be immensely useful to unravel the toxicity mechanism of protein 
aggregation and, in particular, to further clarify several unclear aspects of the HD 
mechanism (Ma & Nussinov 2006; Miller et al. 2010). This may be also of help to identify 
and design specific molecules to hamper polyQ aggregation (Robertson & Bottomley 2010).  
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